Single-center long-term results of vagus nerve stimulation for epilepsy: A 10–17 year follow-up study

@article{Chrastina2018SinglecenterLR,
  title={Single-center long-term results of vagus nerve stimulation for epilepsy: A 10–17 year follow-up study},
  author={Jan Chrastina and Zdeněk Nov{\'a}k and Tom{\'a}{\vs} Zeman and Jitka Ko{\vc}varov{\'a} and Martin Pail and Irena Dole{\vz}alov{\'a} and Jiř{\'i} Jarkovsk{\'y} and Milan Br{\'a}zdil},
  journal={Seizure},
  year={2018},
  volume={59},
  pages={41-47}
}

Tables from this paper

Early Implantation as a Main Predictor of Response to Vagus Nerve Stimulation in Childhood-Onset Refractory Epilepsy

Early vagus nerve stimulator implantation within 5 years of seizure onset was the only predictor of favorable clinical outcome in pediatric patients, and improved quality of life and a low incidence of significant adverse events were observed.

Factors Affecting Vagus Nerve Stimulation Outcomes in Epilepsy

Given the complexity and diversity of factors associated with response to VNS, more clinical studies are needed to establish better paradigm for selection of patients for VNS therapy.

Health Technology Assessment Report on Vagus Nerve Stimulation in Drug-Resistant Epilepsy

Assessment of the clinical, organizational, financial, and economic impact of VNS therapy in drug-resistant epilepsies and the congruity between costs incurred and health service reimbursement indicates VNS as an effective treatment with a potential positive impact on social aspects and on quality of life.

Prediction of Vagal Nerve Stimulation Efficacy in Drug-Resistant Epilepsy (PRECISE): Prospective Study for Pre-implantation Prediction/Study Design

The principal aim of PRediction of vagal nerve stimulation EfficaCy In drug-reSistant Epilepsy (PRECISE) study is to verify the predictability of VNS efficacy by analysis of pre-implantation routine electroencephalogram (EEG).

References

SHOWING 1-10 OF 35 REFERENCES

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy

Long-term, open-label vagus nerve stimulation (VNS) provided seizure reduction similar to or greater than acute studies, for median reductions and for those reaching a ≥50% seizure reduction.

Older Age and Longer Epilepsy Duration Do Not Predict Worse Seizure Reduction Outcome after Vagus Nerve Stimulation

The study did not find worse VNS outcomes, as defined by the 50R or 90R rate, in older adult patients or in patients with a longer epilepsy duration.

Vagus Nerve Stimulation: Clinical Experience in a Large Patient Series

Taking into account the good cost-benefit ratio as well as positive effects on well-being, VNS has to be considered an appropriate strategy for the add-on treatment of drug-resistant seizures, particularly in cases not suitable for epilepsy surgery.

Vagus nerve stimulation: predictors of seizure freedom

Bilateral IED was independently associated with the outcome of VNS, and may facilitate prospective VNS studies enrolling larger numbers of patients to confirm the results.

Effectiveness of vagal nerve stimulation in medication-resistant epilepsy. Comparison between patients with and without medication changes

It is found that the absence of changes in AED can help to optimize the parameters of the stimulator in order to improve its effectiveness, and changes in medication did not improve the outcome.